ipid lowering potential of combined phytosterols and long chain omega-3 fatty acids

Completed

• Conditions: Hyperlipidaemia; Blood - Other blood disorders

• Registration Number: ACTRN12606000453583
• Lead Sponsor: The University of Newcastle

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2006-10-20
• Last Update Posted: 13 January 2020

Recruitment & Eligibility

• Status: Completed
• Sex: All
• Target Recruitment: 60

Inclusion Criteria

Participants with hyperlipidemia, and are not taking any lipid-lowering medications.

Exclusion Criteria

Subjects already taking fish oil supplements and/or regularly consuming phytosterol enriched fat spreads.

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
The primary outcome of this trial is to evaluate the effect of phytosterols and omega-3 fatty acids on plasma cholesterol and triglyceride levels.[Blood samples will be taken at the commencement of the study and again at the completion of the study (3 weeks). A full blood lipid pannel including cholesterol, triglycerides, LDL and HDL will be generated from each sample. Baseline samples will be comparred with post intervention samples to determine the effect of phytosterols and omega-3 fatty acids on plasma cholesterol and triglycerides.]

Secondary Outcome Measures

Name	Time	Method
The secondary outcomes are to evaluate changes in weight, blood pressure and markers of inflammation.[All these outcomes are measured at baseline and again at the completion of the study (3 weeks).]